ABA Sunshine Act Webinar: “Don’t Get Burned By Sunshine: The Latest on the Physician Payments Sunshine Act”
On July 15, 2014, hear an experienced panel discuss important new developments and obligations during this crucial period of the Physician Payments Sunshine Act. Policy & Medicine readers will enjoy an ABA Health Law Section discount. Please click here to register and on the drop down menu for Code select NMPM.
Related Posts
***This is the first discussion that will highlight the impact of the new CMS proposal to remove the CME exemption***
Don’t Get Burned by Sunshine
The first year of reporting obligations for the Physician Payments Sunshine Act is coming to a close on June 30, 2014, when companies must submit detailed 2013 data regarding their interactions with healthcare providers to CMS. However, the rigors of the Sunshine Act do not end there. Pharmaceutical and device manufacturers are required to track their spend data year round. Furthermore, starting in July of this year, companies will be responsible for handling disputes with healthcare professionals. In September, these reports will be published on a searchable public website.
In order to navigate the latest obligations under the Sunshine Act, we invite you to attend an informative webinar entitled Don’t Get Burned By Sunshine: The Latest on the Physician Payments Sunshine Act. The speakers will tackle specific areas of concern, such as dealing with disputes from physicians who don’t want to be reported, promotion related to off-label uses of pharmaceutical products, implications for kickbacks and false claims, and potential inappropriate relationships with academic medical centers or teaching hospitals. This presentation will also address the potential for the use of the database by the media and the government.
Date and Time: July 15, 2014, 12:00-1:30pm ET
Panelists:
Robert C Ciolek, Senior Corporate Counsel at Bristol-Myers Squibb Co.
Stefanie A Doebler, Covington & Burling, LLP, Washington, DC, Special Counsel in the firm’s health care and food and drug practice groups.
Moderator:
Abraham Gitterman, Associate Attorney at Arnold & Porter’s FDA and Healthcare Group in the firm’s Washington, D.C. office.
Credits: 1.50 General CLE Credit Hours